Christopher J Hanley

10PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2026
Histopathology-inferred spatial transcriptomics characterizes the tumor microenvironment in 1,500 head and neck tumors and predicts clinical outcomes.

|May 27, 2026
Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma.

|Mar 18, 2024
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

Nicola J Smith, Ian Reddin, Paige Policelli

|Jan 31, 2023
Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer.

Christopher J Hanley, Sara Waise, Matthew J Ellis

|Nov 10, 2022
ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance.

Massimiliano Mellone, Klaudia Piotrowska, Giulia Venturi

|Jun 25, 2021
Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.

Simon Eschweiler, James Clarke, Ciro Ramírez-Suástegui

Pageof 2

Frequent Collaborators

7 joint publications

Gareth J Thomas

5 joint publications

Christian H Ottensmeier

2 joint publications

Aiman Alzetani

2 joint publications

Ferhat Ay